Evotec SE and Variant Bio Inc. have announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis.   Fibrotic disease, which is characterized by marked and pathogenic build-up of the tissue matrix leading to tissue degeneration in organs, contributes substantially to global mortality and morbidity. Despite the chronic nature of fibrotic conditions, widespread impact on various organs, and substantial disease burden, there is currently no curative tre...